Discuss the significance of NITI Aayog's 'Strategic Roadmap for Making Ayurveda Global' in advancing India's soft power and export economy.

Released on 2 July 2026 by NITI Aayog's Health Division, the 'Strategic Roadmap for Making Ayurveda Global' is the first dedicated policy blueprint to convert a civilisational knowledge system into a globally recognised healthcare and export sector by 2047 [1]. Its significance lies in treating Ayurveda simultaneously as a trade asset and a diplomatic instrument.

Significance for the export economy

• It builds on demonstrated momentum: Ayurvedic products already reach nearly 150 countries, with exports rising from USD 1.09 billion in 2014 to USD 2.16 billion in 2023 [2].
• The three-pillar framework — Availability, Acceptability, Propagation — targets manufacturing scale, international R&D, regulatory compliance and insurance coverage, which are the real non-tariff barriers to traditional medicine trade [2].
• Standardised global education and workforce mobility address a structural gap: of over 3.55 lakh trained practitioners, about 95% remain within India [2], limiting services exports.
• Medical value travel is mainstreamed as an export channel, linking wellness tourism to employment and value creation [1].

Significance for soft power

• The Propagation pillar pursues strategic brand positioning, global visibility and representation in international bodies, converting cultural heritage into institutional influence [2].
• The Ministry of External Affairs is a co-stakeholder alongside the Ministry of Ayush and NITI Aayog, signalling a shift from single-ministry promotion to a whole-of-government health diplomacy approach [3].
• Localisation and cultural adaptability are explicitly built in, avoiding the credibility loss that unadapted export of traditional systems invites [2].
• Alignment with Viksit Bharat@2047 ties Ayurveda to India's larger developmental narrative [1].

Challenges persist — divergent foreign classification of Ayurvedic products as drugs or supplements, limited mutual recognition of practitioners, and a thin peer-reviewed evidence base.

The roadmap's real value is that it reframes globalisation of Ayurveda as a governance and standards problem rather than a promotional one. If matched with rigorous clinical validation, regulatory harmonisation through bilateral agreements, and quality assurance in manufacturing, it can make Ayurveda a credible pillar of India's export basket and its knowledge-based soft power by 2047.